Pharmacokinetics of Cocaine in Pregnancy and Effects on Fetal Maturation

Ahmed MS, Zhou DH, Maulik D, Eldefrawi ME. Characterization of a cocaine binding site in human placenta. Life Sciences 46: 553–561, 1990 Anderson-Brown T, Slotkin TA, Seidler FJ. Cocaine acutely inhibits DNA synthesis in developing rat brain regions: evidence for direct actions. Brain Research 537: 197–202, 1990 Barnett G, Hawks R, Resnick R. Cocaine pharmacokinetics in humans. Journal of Ethnopharmacology 3: 353–366, 1981 Baselt RC. Stability of cocaine in biological fluids. Journal of Chromatography 268: 502–505, 1983 Bauchner H, Zuckerman B, McClain M, Frank D, Fried LE, et al. Risk of sudden infant death syndrome among infants with in utero exposure to cocaine. Journal of Pediatrics 113: 831–834, 1988 Benuck M, Lajtha A, Reith MEA. Pharmacokinetics of systemically administered cocaine and locomotor stimulation in mice. Journal of Pharmacology and Experimental Therapeutics 243: 144–149, 1987 Bingol N, Fuchs M, Diaz V, Stone RK, Gromisch DS. Teratogenicity of cocaine in humans. Journal of Pediatrics 110: 93–96, 1987 Chasnoff IJ. Placental transfer of cocaine: follow-up and outcome. In Transplacental disorders: perinatal detection, treatment, and management, pp. 57–65, Alan R. Liss Inc., New York, 1990 Chasnoff IJ, Burns KA, Burns WJ. Cocaine use in pregnancy: perinatal morbidity and mortality. Neurotoxicology and Teratology 9: 291–293, 1987a Chasnoff IJ, Burns WJ, Schnoll SH, Burns KA. Cocaine use in pregnancy. New England Journal of Medicine 313: 666–669, 1985 Chasnoff IJ, Bussey ME, Savich R, Stack CM. Perinatal cerebral infarction and maternal cocaine use. Journal of Pediatrics 108: 456–459, 1986 Chasnoff IJ, Chisum GM, Kaplan WE. Maternal cocaine use and genitourinary tract malformations. Teratology 37: 201–204, 1988 Chasnoff IJ, Griffith DR, MacGregor S, Dirkes K, Burns KA. Temporal patterns of cocaine use in pregnancy. Journal of the American Medical Association 261: 1741–1744, 1989a Chasnoff IJ, Hunt CE, Kletter R, Kaplan D. Prenatal cocaine exposure is associated with respiratory pattern abnormalities. American Journal of Diseases of Children 143: 583–587, 1989b Chasnoff IJ, Lewis DE, Griffith DR, Willey S. Cocaine and pregnancy: clinical and toxicological implications for the neonate. Clinical Chemistry 35: 1276–1278, 1989c Chasnoff IJ, Lewis DE, Squires L. Cocaine intoxication in a breastfed infant. Pediatrics 80: 836–838, 1987b Chávez GF, Mulinare J, Cordero JF. Maternal cocaine use during early pregnancy as a risk factor for congenital urogenital anomalies. Journal of the American Medical Association 262: 795–798, 1989 Chouteau M, Namerow PB, Leppert P. The effect of cocaine abuse on birth weight and gestational age. Obstetrics and Gynecology 72: 351–354, 1988 Church MW, Dintcheff BA, Gessner PK. Dose-dependent consequences of cocaine on pregnancy outcome in the Long-Evans rat. Neurotoxicology and Teratology 10: 51–58, 1988 Church MW, Overbeck GW, Andrzejczak AL. Prenatal cocaine exposure in the Long-Evans rat I: dose-dependent effects on gestation, mortality, and postnatal maturation. Neurotoxicology and Teratology 12: 327–334, 1990 Cone EJ, Kumor K, Thompson LK, Sherer M. Correlation of saliva cocaine levels with plasma levels and with pharmacologic effects after intravenous cocaine administration in human subjects. Journal of Analytical Toxicology 12: 200–206, 1988 Das Gupta V. Stability of cocaine hydrochloride solutions at various pH values as determined by high-pressure liquid chromatography. International Journal of Pharmaceutics 10: 249–257, 1982 DeVane CL, Simpkins JW, Miller RL, Braun SB. Tissue distribution of cocaine in the pregnant rat. Life Sciences 45: 1271–1276, 1989 Dixon SD, Bejar R. Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: incidence and clinical correlates. Journal of Pediatrics 115: 770–778, 1989 Divakaran P, Joiner F, Rigor BM, Wiggins RC Accumulation and persistence of halothane in adult and fetal rat brain as a result of subanesthetic exposure. Journal of Neurochemistry 34: 1543–1546, 1980 Divakaran P, Rigor BM, Wiggins RC. Halothane accumulation in rat brain and liver. Neurochemical Research 6: 77–85, 1981 Dombrowski MP, Wolfe HM, Welch RA, Evans MI. Cocaine abuse is associated with abruptio placentae and decreased birth weight, but not shorter labor. Obstetrics and Gynecology 77: 139–141, 1991 Dougherty PM, Qiao JT, Wiggins RC, Dafny N. Microintophoresis of cocaine, desipramine, sulphiride, methysergide, and naloxone in Habenula and parafasciculus. Experimental Neurology 108: 241–246, 1990 Dow-Edwards D, Fico TA, Osman M, Gamgaris Z, Hutchings DE. Comparison of oral and subcutaneous routes of cocaine administration on behavior, plasma drug concentration and toxicity in female rats. Pharmacology Biochemistry and Behavior 33: 167–173, 1989 Dow-Edwards DL, Freed LA, Fico TA. Structural and functional effects of prenatal cocaine exposure in adult rat brain. Developmental Brain Research 57: 263–268, 1990 El-Bizri H, Guest I, Varma DR. Effects of cocaine in rat embryo development in vivo and in cultures. Pediatric Research 29: 187–190, 1991 Frank DA, Bauchner H, Parker S, Huber AM, Kyei-Aboagye K, et al. Neonatal body proportionality and body composition after in utero exposure to cocaine and marijuana. Journal of Pediatrics 117: 622–626, 1990 Fulroth R, Phillips B, Durand DJ. Perinatal outcome of infants exposed to cocaine and/or heroin in utero. American Journal of Diseases of Children 143: 905–910, 1989 Gilbert WM, Lafferty CM, Benirschke K, Resnik R. Lack of specific placental abnormality associated with cocaine use. American Journal of Obstetrics and Gynecology 163: 998–999, 1990 Gingras JL, Weese-Mayer D. Maternal cocaine addiction II: an animal model for the study of brainstem mechanisms operative in sudden infant death syndrome. Medical Hypotheses 33: 231–234, 1990 Graham K, Koren G, Klein J, Schneiderman J, Greenwald M. Determination of gestational cocaine exposure by hair analysis. Journal of the American Medical Association 262: 3328–3330, 1989 Hadeed AJ, Siegel SR. Maternal cocaine use during pregnancy: effect on the newborn infant. Pediatrics 84: 205–210, 1989 Heyser CJ, Chen WJ, Miller J, Spear NE, Spear LP. Prenatal cocaine exposure induces deficits in pavlovian conditioning and sensory preconditioning among infant rat pups. Behavioral Neuroscience 104: 955–963, 1990 Holmstead B, Lindgren JE, Rivier L. Cocaine in blood of coca chewers. Journal of Ethnopharmacology 1: 69–78, 1979 Hume RF, O’Donnell KJ, Stanger CL, Killam AP, Gingras JL. In utero cocaine exposure: observations of fetal behavioral state may predict neonatal outcome. American Journal of Obstetrics and Gynecology 161: 685–690, 1989 Hutchings DE, Fico TA, Dow-Edwards DL. Prenatal cocaine: maternal toxicity, fetal effects and locomotor activity in rat offspring. Neurotoxicology and Teratology 11: 65–69, 1989 Inaba T, Stewart DJ, Kalow W. Metabolism of cocaine in man. Clinical Pharmacology and Therapeutics 23: 547–552, 1978 Jatlow PI. Drug of abuse profile: cocaine. Clinical Chemistry 33: 66B–71B, 1987 Javid JI, Musa MN, Fischman M, Schuster CR, Davis JM. Kinetics of cocaine in humans after intravenous and intranasal administration. Biopharmaceutics and Drug Disposition 4: 9–18, 1983 Jeffcoat AR, Perez-Reyes M, Hill JM, Sadler BM, Cook CE. Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking. Drug Metabolism and Disposition 17: 153–159, 1989 Khan M, Gupta PK, Cristie R, Nangia A, Winter H, et al. Determination of pharmacokinetics of cocaine in sheep by liquid chromatography. Journal of Pharmaceutical Sciences 76: 39–43, 1987 Lipshultz SEE, Frassica JJ, Orav EJ. Cardiovascular abnormalities in infants prenatally exposed to cocaine. Journal of Pediatrics 118: 44–51, 1991 Little BB, Snell LM, Klein VR, Gilstrap III LC. Cocaine abuse during pregnancy: maternal and fetal implications. Obstetrics and Gynecology 73: 157–160, 1989 MacGregor SN, Keith LG, Bachicha JA, Chasnoff IJ. Cocaine abuse during pregnancy: correlation between prenatal care and perinatal outcome. Obstetrics and Gynecology 74: 882–885, 1989 MacGregor SN, Keith LG, Chasnoff IJ, Rosner MA, Chisum GM, et al. Cocaine use during pregnancy: adverse perinatal outcome. American Journal of Obstetrics and Gynecology 157: 686–690, 1987 Mahalik MP, Gautieri RF, Mann Jr DE. Teratogenic potential of cocaine hydrochloride in CF-1 mice. Journal of Pharmaceutical Sciences 69: 703–706, 1980 Mastrogiannis DS, Decavalas GO, Verma U, Tejani N. Prenatal outcome after recent cocaine usage. Obstetrics and Gynecology 76: 8–11, 1990 Mayersohn M, Perrier D. Kinetics of pharmacologic response to cocaine. Research Communications in Chemical Pathology and Pharmacology 22: 465–474, 1978 Mercado A, Johnson Jr G, Calver D, Sokol RJ. Cocaine, pregnancy, and postpartum intracerebral hemorrhage. Obstetrics and Gynecology 73: 467–468, 1989 Misra AL, Nayak PK, Bloch R, Mulé SJ. Estimation and disposition of [3H]benzoylecgonine and pharmacological activity of some cocaine metabolites. Journal of Pharmacy and Pharmacology 27: 784–786, 1975 Mitchell M, Sabbagha RE, Keith L, MacGregor S, Mota JAM, et al. Ultrasonic growth parameters in fetuses of mothers with primary addiction to cocaine. American Journal of Obstetrics and Gynecology 159: 1104–1109, 1988 Moore TR, Sorg J, Miller L, Key TC, Resnik R. Hemodynamic effects of intravenous cocaine on the pregnant ewe and fetus. American Journal of Obstetrics and Gynecology 155: 883–888, 1986 Neerhof MG, MacGregor SN, Retzky SS, Sullivan TP. Cocaine abuse during pregnancy: peripartum prevalence and perinatal outcome. American Journal of Obstetrics and Gynecology 161: 633–638, 1989 Neuspiel DR, Hamel SC, Hochberg E, Greene J, Campbell D. Maternal cocaine use and infant behavior. Neurotoxicology and Teratology 13: 229–233, 1991 Oro AS, Dixon SD. Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates. Journal of Pediatrics 111: 571–578, 1987 Petitti DB, Coleman C. Cocaine and the risk of low birth weight. American Journal of Public Health 80: 25–28, 1990 Qiao JT, Dougherty PM, Wiggins RC, Dafny N. Effects of microiontophoretic application of cocaine, alone and with receptor antagonists, upon the neurons of the medial prefrontal cortex, nucleus accumbens and caudate nucleus of rats. Neuropharmacology 29: 379–385, 1990 Reith MEA, Benuck M, Lajtha A. Cocaine disposition in the brain after continuous or intermittent treatment and locomotor stimulation in mice. Journal of Pharmacology and Experimental Therapeutics 243: 281–287, 1987 Rosenstein BJ, Wheeler JS, Heid PL. Congenital renal abnormalities in infants with in utero cocaine exposure. Journal of Urology 144: 110–112, 1990 Ryan L, Ehrlich S, Finnegan L. Cocaine abuse in pregnancy: effects on the fetus and newborn. Neurotoxicology and Teratology 94: 295–299, 1987 Shaw GM, Swan SH. Maternal use of cocaine during pregnancy and congenital cardiac anomalies. Journal of Pediatrics 118: 167–168, 1991 Sikes RW, Fuller GN, Colbert C, Chronister RB, DeFrance J, et al. The relative numbers of oligodendroglia in different brain regions of normal and postnatally undernourished rats. Brain Research Bulletin 6: 385–391, 1981 Sobrian SK, Burton LE, Robinson NL, Ashe WK, James H, et al. Neurobehavioral and immunological effects of prenatal cocaine exposure in rat. Pharmacology Biochemistry and Behavior 35: 617–629, 1990 Spear LP, Frambes NA, Kirstein CL. Fetal and maternal brain and plasma levels of cocaine and benzoylecgonine following chronic subcutaneous administration of cocaine during gestation in rats. Psychopharmacology 97: 427–432, 1989a Spear LP, Kirstein CL, Bell J, Yoottansumpun V, Greenbaum R, et al. Effects of prenatal cocaine exposure on behavior during the early postnatal period. Neurotoxicology and Teratology 11: 57–63, 1989b Spires MC, Gordon EF, Choudhuri M, Maldonado E, Chan R. Intracranial hemorrhage in a neonate following prenatal cocaine exposure. Pediatric Neurology 5: 324–326, 1989 Stockard CR. Developmental rate and structural expression: an experimental study of twins, ‘double monsters,’ and single deformities, and the interaction among embryonic organs during their origin and development. American Journal of Anatomy 28: 115–227, 1921 Strum DP, Johnson BH, Eger EI. Elimination of anaesthetics from rabbit brain. Science 234: 1586–1588, 1986 van de Bor M, Walther FJ, Ebrahimi M. Decreased cardiac output in infants of mothers who abuse cocaine. Pediatrics 85: 30–32, 1990 Van Dyke C, Jatlow P, Ungerer J, Barash PG, Byck R. Oral cocaine: plasma concentrations and central effects. Science 200: 211–213, 1978 Wiggins RC. Myelin development and nutritional insufficiency. Brain Research Reviews 4: 151–175, 1982 Wiggins RC. Myelination: a critical stage in development. Neurotoxicology 7: 103–120, 1986 Wiggins RC, Rolsten C, Ruiz B, Davis CM. Pharmacokinetics of cocaine: basic studies of route, dosage, pregnancy, and lactation. Neurotoxicology 10: 367–382, 1989 Wiggins RC, Ruiz B. Development under the influence of cocaine I: a comparison of the effects of cocaine treatment and resultant undernutrition on pregnancy and early growth in a large population of rats. Metabolic Brain Disease 5: 85–99, 1990a Wiggins RC, Ruiz B. Development under the influence of cocaine II: comparison of the effects of maternal cocaine and associated undernutrition on brain myelin development in the offspring. Metabolic Brain Disease 5: 101–109, 1990b Wilkinson P, Van Dyke C, Jatlow P, Barash P, Byck R. Intranasal and oral cocaine kinetics. Clinical Pharmacology and Therapeutics 27: 386–394, 1980 Zuckerman B, Frank DA, Hingson R, Amaro H, Levenson SM, et al. Effects of maternal marijuana and cocaine use on fetal growth. New England Journal of Medicine 320: 762–768, 1989